Targeting HIV reservoirs and reconstituting the immune system. Second annual meeting Research Institute for Genetic and Human Therapy April 18-19, 1999 Washington, DC

AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1597-617. doi: 10.1089/088922299309649.
No abstract available

Publication types

  • Congress

MeSH terms

  • AIDS Vaccines / immunology
  • Adult
  • Animals
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use
  • Clinical Trials as Topic
  • Cohort Studies
  • Cytopathogenic Effect, Viral
  • Dendritic Cells / immunology
  • Dendritic Cells / transplantation
  • Dendritic Cells / virology
  • Disease Reservoirs*
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Female
  • Genetic Therapy
  • Genetic Vectors / genetics
  • Genetic Vectors / therapeutic use
  • HIV Infections / immunology*
  • HIV Infections / prevention & control
  • HIV Infections / therapy
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • HIV-1 / immunology
  • HIV-1 / physiology
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Hydroxyurea / administration & dosage
  • Hydroxyurea / therapeutic use
  • Immunity, Cellular
  • Immunization, Passive
  • Immunotherapy, Adoptive
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / virology
  • Macaca fascicularis
  • Male
  • Primates / virology
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Salvage Therapy
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / virology
  • Simian Immunodeficiency Virus / physiology
  • T-Lymphocytes, Cytotoxic / immunology
  • Vaccines, DNA / immunology

Substances

  • AIDS Vaccines
  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Vaccines, DNA
  • Hydroxyurea